Applications for innovative cancer research
The Damon Runyon-Rachleff Innovation Award offered by the Damon Runyon Cancer Research Foundation is designed to provide support for the next generation of exceptionally creative thinkers with high-risk/high-reward ideas that have the potential to significantly impact the understanding of and/or approaches to the prevention, diagnosis, or treatment of cancer.
The award will provide funding to extraordinary early-career researchers who have an innovative idea but lack sufficient preliminary data to obtain traditional funding. Research supported by the award must be novel, exceptionally creative, and, if successful, have a strong potential for high impact in the cancer field. Basic and translational/clinical projects will be considered.
Applicants with a background in multiple disciplines are encouraged to apply, and joint submissions from two collaborators working in different disciplines will be considered.
Grants of $200,000 per year for two years will be awarded in stage one, along with the opportunity for up to two additional years of funding (up to four years total for $800,000). Stage two support for years three and four will be granted to those awardees who demonstrate progress on their proposed research during years one and two of the award.
To be eligible, applicants must be conducting independent research at a U.S. research institution, though they need not be U.S. citizens. Applicants must have received an MD, DO, PhD, or MD/PhD degree(s) from an accredited institution.
For complete program guidelines and application instructions, see the Damon Runyon Cancer Research Foundation website.
Submissions to this sponsor/donor are managed by the Office of Corporate and Foundation Relations. Please contact your unit-assigned ASUF Director of Development or Research Advancement Specialist at your earliest convenience to ensure ASU's strategic coordination and management of funding applications.